Fundraising Fox

Quvium

Woburn, US · Founded 2009 · 2 known investors

Quvium operates an affiliate review site that ranks and compares online casinos holding Curaçao licences (non-GAMSTOP casinos) for UK players, covering welcome offers, payment methods, game catalogues and safer-gambling tools. The site earns commission from some listed operators.

Also known as Quvium UK Ltd.

Founders & leadership

TSThomas Smith
Thomas SmithinExecutive
SP
Steven P. SchmidtinExecutive

Board

ZN
Zeev NeuwirthBoard director
MM
Mark MurckoBoard director
AO
Andrew O'BrienBoard director
RH
R. Hale AndrewsBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$445K disclosed across 1 round · 2011

$445KraisedJan 2012 · 15 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zeev NeuwirthDirector
  • Mark MurckoDirector
  • Thomas SmithExecutive Officer, Director
  • Andrew O'BrienDirector
  • Steven P. SchmidtExecutive Officer, Director
  • R. Hale AndrewsDirector
Offering amount
$500K
Amount sold
$445K
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
Jan 2011
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Quvium UK Ltd. is a privately held medical device company based at Discovery Park, Ramsgate Road, Sandwich, Kent, in the United Kingdom. It develops constant-use solutions for chronic and acute respiratory conditions, drawing on a team with backgrounds in pharmaceuticals, medical devices, technology and entrepreneurship.

The company's first commercialised product is Sonasure, a patented wearable cough monitor intended for asthma sufferers — particularly children — as well as patients with cystic fibrosis and chronic obstructive pulmonary disease (COPD). The personalised wearable monitor is designed to help predict and prevent attacks or flare-ups, with the stated aim of reducing emergency room visits, hospitalisations and deaths; the company cites estimates that 75% of asthma hospital admissions are avoidable and as many as 90% of asthma deaths are preventable.

Quvium has established a Clinical Advisory Council composed of respiratory physicians, cough researchers and general practitioners, and has formed product development and manufacturing partnerships to support a cost-effective, market-driven product.

Founding story

Quvium UK Ltd. was founded in 2013 and is headquartered in Kent, United Kingdom.

Latest developments

An external engineering engagement with OLogic, Inc. covering hardware, software, electronics and industrial design ran from 2017 to 2021.

Full profile — market position, technology, go-to-market, geography, history

Market position

A private medical device developer operating in the respiratory monitoring segment, positioned around continuous, wearable cough monitoring and supported by a clinical advisory council of respiratory physicians and cough researchers.

Technology

Quvium's technology centres on Sonasure, a patented wearable cough monitor designed for continuous use. The device monitors coughing to help predict and prevent attacks or flare-ups associated with asthma, cystic fibrosis and COPD. Hardware design, electronics design, industrial design and software support for the company were provided by OLogic, Inc. between 2017 and 2021.

Go-to-market

Patients with chronic and acute respiratory conditions — asthma sufferers, in particular children, along with cystic fibrosis and COPD patients — and their families and carers.

Geography

Headquartered at Discovery Park in Sandwich, Kent, United Kingdom, with one facility in one country; product design work was carried out with a US-based engineering partner.

History

Founded in 2013, Quvium built out a Clinical Advisory Council of respiratory physicians, cough researchers and general practitioners, and established product development and manufacturing partnerships. Between 2017 and 2021 it worked with Silicon Valley robotics and electronics consultancy OLogic, Inc., which provided hardware design, software support, electronics design and industrial design services for the company.

Compiled by commissioned research from 4 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Countries of operationJan 20261
FacilitiesJan 20261 facilities

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 1

launches, deals, and filings
Jan 2017
Product design engagement with OLogic, Inc. (2017–2021)

OLogic, Inc., a Silicon Valley robotics and electronics consultancy, provided hardware design, software support, electronics design and industrial design for Quvium UK on a project dated 2017 to 2021.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 4

primary sources listed

4 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Quvium do?
Quvium UK Ltd. is a Kent-based medical device company developing wearable, constant-use monitoring for respiratory conditions.
Who are Quvium's investors?
Quvium's investors include Creative UK, Vala Capital.
How much funding has Quvium raised?
Quvium has disclosed $445K raised across 1 round.
Where is Quvium headquartered?
Quvium is headquartered in Woburn, US.